WHO ICTRP trial
Flexible fluorescence-cystoscopy in non-muscle-invasive bladder cancer
JPRN-jRCTs031230643 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs031230643 |
|---|---|
| Public title | Flexible fluorescence-cystoscopy in non-muscle-invasive bladder cancer |
| Scientific title | Oral 5-aminolevulinic acid mediated flexible fluorescence-cystoscopy in non-muscle-invasive bladder cancer - Flexible fluorescence-cystoscopy in non-muscle-invasive bladder cancer |
| Primary sponsor | Yoshida Soichiro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Non-muscle invasive bladder cancer |
| Interventions | (1)5-ALA administration As a general rule, patients are admitted to the hospital the day before TURBT, as in regular medical treatment. On the day of TURBT, 3 hours (range: 2 to 4 hours) before the start of surgery, 20 mg/kg of 5-ALA… |
| Registration date | Feb 19, 2024 |
| Target size | 110 |
| Secondary IDs | Nil known |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: